MethylDetect ApS is a supplier of DNA methylation detection kits. MethylDetect kits are based on the Methylation-Sensitive High-Resolution Melting technology (MS-HRM) enabling highly sensitive, cost effective and user-friendly detection of DNA methylation changes in biological material. In the last decade, studies of DNA methylation have been one of the fastest growing area of R&D. This is due to increasing evidence that changes of methylation can be utilized as a biomarker in all aspects of clinical disease management including: risk assessment, early diagnosis, personalization of treatment, and post treatment disease monitoring. The main stake holders in need for the technology for methylation detection are: • Research - for basic research of the pathology of the disease • Biotech & pharma industry - for research and development of compounds modifying DNA methylation useful in epigenetic therapies • Clinics – to develop disease related methylation changes as biomarkers allowing for prevention, diagnosis, prognosis of the disease With the research use only products on the market, the ambition of MethylDetect is to bring our products into routine use for patient care in near future.